Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01352923

Study of Polymorphisms in pear1 Gene Link to Platelet Activation and Signaling Pathway Variations

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Accepted

Summary

In this study PEAR1 polymorphisms effects will be analyze in blood platelets to determine how PEAR1 regulates platelet activation.

Detailed description

Several large-scale studies have confirmed the long held notion that platelet responses to different agonists are highly variable, within well defined populations of healthy donors. Single nucleotide polymorphisms in genes encoding platelet proteins can explain the wide range of responses to standard platelet agonists. Yet, numerous SNPs point towards proteins with previously unknown function in platelets, wich modulate the complex network of signaling events that regulate platelet function and further augment variability. PEAR1 is mainly expressed in platelets and endothelial cells. A few studies have linked SNPs in PEAR1 with decreased or increased platelet responses to various agonists. However, hitherto, no direct functional studies have been carried out to determine whether and how PEAR1 modulate intracellular signaling pathways relevant for platelet function.

Conditions

Interventions

TypeNameDescription
OTHERblood testpreparation of blood platelets

Timeline

Start date
2011-05-01
Primary completion
2012-05-01
Completion
2012-05-01
First posted
2011-05-12
Last updated
2024-06-28

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01352923. Inclusion in this directory is not an endorsement.